Page last updated: 2024-10-27

flurbiprofen and Lung Diseases

flurbiprofen has been researched along with Lung Diseases in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Lung Diseases: Pathological processes involving any part of the LUNG.

Research Excerpts

ExcerptRelevanceReference
"Postoperative pain was assessed using the visual analog scale (VAS)."2.87Comparison of the analgesic effects of modified continuous intercostal block and paravertebral block under surgeon's direct vision after video-assisted thoracic surgery: a randomized clinical trial. ( Kadomatsu, Y; Mori, S; Uchiyama, M; Ueno, H; Wakai, K, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kadomatsu, Y1
Mori, S1
Ueno, H1
Uchiyama, M1
Wakai, K1

Trials

1 trial available for flurbiprofen and Lung Diseases

ArticleYear
Comparison of the analgesic effects of modified continuous intercostal block and paravertebral block under surgeon's direct vision after video-assisted thoracic surgery: a randomized clinical trial.
    General thoracic and cardiovascular surgery, 2018, Volume: 66, Issue:7

    Topics: Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Catheterization, Peripheral; Drug

2018